(Q83292295)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264827%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264827%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Samir Sejpal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264827%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Ritsuko Komaki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264827%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Anne Tsao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264827%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Joe Y Chang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264827%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Zhongxing Liao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264827%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Xiong Wei

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264827%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Pamela K Allen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264827%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Charles Lu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264827%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Michael Gillin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264827%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

James D Cox

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264827%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

24 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264827%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

number of pages

10

1 reference

inferred from page(s)

published in

Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264827%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264827%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264827%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

3004-3013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264827%20AND%20SRC:MED&resulttype=core&format=json

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

Initial Evaluation of Treatment-Related Pneumonitis in Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Concurrent Chemotherapy and Intensity-Modulated Radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCL

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

Randomized double-blind trial of combined modality treatment with or without amifostine in unresectable stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

A phase III randomized evaluation of amifostine in stage IIIA/IIIB non-small cell lung cancer patients receiving concurrent carboplatin, paclitaxel, and radiation therapy followed by gemcitabine and cisplatin intensification: preliminary findings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25848

7 January 2021

Identifiers

DOI

10.1002/CNCR.25848

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264827%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference